Skip to content

AbbVie Inc. CDR Price, Chart & Factor Exposure

Free Data & Analytics Access
AbbVie Inc. CDR · E.ABBV.NEO · Canada
Use symbol E.ABBV.NEO in our API & Excel add-in to retrieve this data ↓
—
(—)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum —
Trend —
Bubble Risk LOW
Realised Volatility (20D) —

AbbVie Inc. CDR Price Chart

MacroFinance.ai

AbbVie Inc. CDR Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
AbbVie Inc. CDR
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
AbbVie Inc. CDR
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
AbbVie Inc. CDR
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for AbbVie Inc. CDR, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on AbbVie Inc. CDR

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

About AbbVie Inc. CDR (Canada)

AbbVie Inc. CDR is a listed security in Canada. This page shows the latest price and daily change, a price chart, its factor exposures and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on AbbVie Inc

Frequently asked questions

What is AbbVie Inc. CDR?
AbbVie Inc. CDR is a listed security in Canada. On MacroFinance its page shows the latest price and daily change, a price chart, its factor exposures and free historical data.
What factors affect AbbVie Inc. CDR?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to AbbVie Inc. CDR, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Where can I download free AbbVie Inc. CDR historical data?
In the Free historical data section of this page: the last 10 years of AbbVie Inc. CDR daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free AbbVie Inc. CDR historical data (last 10 years)

Browse or instantly download the last 10 years of AbbVie Inc. CDR daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.ABBV.NEO&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-05-2930.19
2026-05-2830.53
2026-05-2730.01
2026-05-2629.71
2026-05-2530.83
2026-05-2230.28
2026-05-2130.12
2026-05-2029.84
2026-05-1929.89
2026-05-1529.47
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.